The Participation Blog

Author name: John Godec

Making Change

You’ve probably noticed that we’re in a hard-to-explain business. I’ve largely given up trying to describe what I do for a living if the person asking isn’t already connected to it in some way. As Run DMC said, “It’s tricky.” There’s no simple soundbite answer, but one accurate ...
read more →

Is Your Organization Ethical?

There have been times when companies (mostly) would call asking for help with some kind of embarrassing issue that they were afraid the public would find out about. Someone in senior management would typically ask, “What can we do to make sure people see us as being trustworthy and credible?” ...
read more →

Consensus Through a Different Lens

Any work that you’re doing with the public has to start with defining the problem or challenge that you’re trying to solve. This means that there needs to be a common, agreed upon understanding and belief among everyone that a problem exists in the first place, and exactly what that ...
read more →

FOIA Factoid

In 2022, the U.S. Federal Government received 930,000 Freedom of Information Act (FOIA) requests. And that’s just the feds. If you’ve worked in the public sector at any level, I expect you’ve dealt with public information requests and the challenges that they create. There’s a baked in tension between the ...
read more →

Civics 101

Back when dinosaurs roamed the Earth and my friends and I had to ride our chickens to school (couldn’t afford horses), we were taught a quaint subject called “civics” and/or “government.” That gradually came to an end as school curricula changed and narrowed. And that lack of basic understanding of ...
read more →

Facilitate Don’t Dominate

Getting the best out of people and nudging them into some level of cooperation is a learnable art and skillset. It’s sort’a required for the work that we do. Although we do deal with students and clients who sometimes just oversee the function of public participation but don’t actually work ...
read more →

Pass That Dog Down

Eli Lilly and Company announced this month that they’re reducing the price of their most common insulin by 70% and capping patient out-of-pocket insulin costs at $35 or less a month. It might make cynical people wonder why. But in spite of how things feel these days, the overall arch ...
read more →